| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
194 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,794 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,046 |
| 424/277.1 |
Cancer cell or component thereof |
385 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
209 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
134 |
| 424/193.1 |
Conjugate or complex |
846 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
970 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
468 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
250 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
245 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
585 |
| 424/204.1 |
Virus or component thereof |
999 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6683052 |
Lipopeptides containing an interferon-.gamma. fragment, and uses thereof in pharmaceutical compositions |
Jan. 27, 2004 |
| 6680055 |
Mycolactone and related compounds, compositions and methods of use |
Jan. 20, 2004 |
| 6680058 |
Compositions and methods for contraception in or sterilization of mammals |
Jan. 20, 2004 |
| 6680061 |
Coccidiosis vaccines |
Jan. 20, 2004 |
| 6676942 |
Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines |
Jan. 13, 2004 |
| 6676943 |
Human complement C3-degrading protein from Streptococcus pneumoniae |
Jan. 13, 2004 |
| 6676944 |
Vaccine containing a peroxiredoxin and/or a .beta.-tubulin |
Jan. 13, 2004 |
| 6676946 |
Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof |
Jan. 13, 2004 |
| 6676958 |
Adjuvant composition for mucosal and injection delivered vaccines |
Jan. 13, 2004 |
| 6677302 |
Compositions and methods for the treatment of viral disorders |
Jan. 13, 2004 |
| 6677428 |
Mammaglobin, a secreted mammary-specific breast cancer protein |
Jan. 13, 2004 |
| 6673348 |
Heat shock protein-based vaccines and immunotherapies |
Jan. 6, 2004 |
| 6673349 |
Method of inactivating microorganisms |
Jan. 6, 2004 |
| 6673350 |
Tumor associated peptide and uses thereof |
Jan. 6, 2004 |
| 6673353 |
Tuberculosis vaccine |
Jan. 6, 2004 |
| 6673574 |
Oral delivery of peptides using enzyme-cleavable membrane translocators |
Jan. 6, 2004 |
| 6669940 |
Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof |
Dec. 30, 2003 |
| 6669947 |
Stratified and cryogenically stored vaccines, process for their preparation |
Dec. 30, 2003 |
| 6667038 |
Prevention, diagnosis and treatment of lyme disease |
Dec. 23, 2003 |
| 6667040 |
Bovine footrot treatment and prevention |
Dec. 23, 2003 |
| 6663862 |
Reagents for detection and purification of antibody fragments |
Dec. 16, 2003 |
| 6663863 |
Method of inhibiting stenosis and restenosis |
Dec. 16, 2003 |
| 6663865 |
Tumor necrosis factor antagonists and their use in endometriosis |
Dec. 16, 2003 |
| 6663873 |
Antigenic preparation for treatment or prevention of helicobacter infection |
Dec. 16, 2003 |
| 6664066 |
Modified Morbillivirus V proteins |
Dec. 16, 2003 |
| 6664096 |
Methods for improved diagnosis and treatment of mycobacterial infections |
Dec. 16, 2003 |
| 6664370 |
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
Dec. 16, 2003 |
| 6660261 |
Bordetella strain expressing the FHA hybrid, liposomes and vaccines |
Dec. 9, 2003 |
| 6660266 |
Reversal of proinflammatory response by ligating the macrophage Fc.gamma.RI receptor |
Dec. 9, 2003 |
| 6660267 |
Prevention and treatment of sepsis |
Dec. 9, 2003 |
| 6660268 |
Proteasome regulation of NF-KB activity |
Dec. 9, 2003 |
| 6660269 |
Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
Dec. 9, 2003 |
| 6660270 |
Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection |
Dec. 9, 2003 |
| 6660274 |
Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
Dec. 9, 2003 |
| 6660275 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Dec. 9, 2003 |
| 6660840 |
Methods for enhancement of protective immune responses |
Dec. 9, 2003 |
| 6656469 |
Nicotine immunogen |
Dec. 2, 2003 |
| 6656470 |
Vaccine composition, method of preparing the same, and method of vaccinating vertebrates |
Dec. 2, 2003 |
| 6656480 |
Compositions and methods for the treatment and diagnosis of breast cancer |
Dec. 2, 2003 |
| 6656679 |
Heat shock protein-based vaccines and immunotherapies |
Dec. 2, 2003 |
| 6656719 |
Serum-free, low-protein media for rotavirus vaccine production |
Dec. 2, 2003 |
| 6652847 |
Attenuated strains of leishmania and uses thereof |
Nov. 25, 2003 |
| 6652858 |
Use of OX-2 to suppress an immune response |
Nov. 25, 2003 |
| 6652862 |
Biologically active bactericidal/permeability-increasing protein fragments |
Nov. 25, 2003 |
| 6653444 |
Polypeptides comprising a B7 extracellular domain |
Nov. 25, 2003 |
| 6653461 |
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of Chlamydia trachomatis |
Nov. 25, 2003 |
| 6649165 |
Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using soluble Fc.gamma.RIII receptors |
Nov. 18, 2003 |
| 6649167 |
Papillomavirus truncated L1 protein and fusion protein constructs |
Nov. 18, 2003 |
| 6649170 |
Adjuvant combinations for immunization composition and vaccines |
Nov. 18, 2003 |
| 6649744 |
Rnase P polypeptides, polynucleotides, and methods using their mechanisms of action |
Nov. 18, 2003 |
|
|
|
